Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
F-Prime Capital
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 10, 2022
New executive CBC-backed ABio-X appoints pharmaceutical and healthcare veteran Dr. Jeffrey Jonas as CEO · ktla.com
2021
Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Sandgarden is an incubator, by design. The most capital-efficient company-making machine out there: one team, one playbook, one product…

Dedicated to the power of light, innovative light engines and OEM applications from Lumencor help life and materials sciences push the…

Creoptix enables life scientists to accelerate discovery by providing cutting-edge tools for molecular interaction analysis.

ThinkCyte develops single-cell analysis technologies that combine advanced optics, machine learning and biotechnology to support…

ONI offers innovative super-resolution microscopy systems including Aplo Scope, Nanoimager, and Aplo Flow. Explore dSTORM, PALM, DNA-PAINT…

The Cellanome live-cell, multimodal platform links molecular, functional, and temporal data from the same cells over time. Our proprietary…
News
BeiGene and Ensem Therapeutics Announce Partnership to Advance Differentiated CDK2 Inhibitor
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. & WALTHAM, Mass.-(BUSINESS WIRE)-BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, and Ensem Therapeutics, Inc. (ENSEM), a biotechnology company focusing on high-value a
Read more
Report
Karly (Jiayu) Liu
As a small organization, I get to learn from some of the best in the business. Our collaborative culture helps drive innovation, which is exciting for my career progression. The post Karly (Jiayu) Liu appeared first on ABio-X.
Read more
Report
Terry Ying
Terry has more than 15 years of IT experience in large multinational companies. Previously, he was the Senior Infrastructure Engineer at LVMH Perfumes & Cosmetics (Shanghai) and has held roles of increasing responsibility at Water Technologies, Bosch, Mat
Read more
Report
Tianze Tao
Tianze has a MS degree in Pharmaceutical Sciences from The University of Southern California and a BS degree in Clinical Nutrition from UC Davis. He was inspired to pursue a career in pharmaceuticals and life sciences after the emergence of COVID-19, stri
Read more
Report
Francesca Solitro
Francesca graduated from Bryant University in 2020 with a degree in Human Resources Management and Communications. She joins the ABio-X team from Sirtex Medical, where she spent 4.5 years in Human Resources, progressing to HR Generalist. The post Francesc
Read more
Report
Karly (Jiayu) Liu
Prior to joining ABio-X, Karly was a market analyst at a Boston-based law firm. Since joining ABio-X, Karly assists our member companies build their finance and procurement structures in the US. She also supports the audits and company financings. Karly r
Read more
Report
Tracy Yeo, PHD
Prior to joining ABio-X, Tracy was Senior Director of Strategy and Business Development at RVAC Medicines, an innovative mRNA company. Previously, Tracy served as Director of Consulting at ChinaBio Group, where she led more than 50 consulting projects ass
Read more
Report
Sean Fu, PhD, MBA
Sean Fu is an experienced leader and proven entrepreneur. Sean was co-founder and CEO of RVAC Medicines, an mRNA company established in 2021, raised $170 million and successfully brought two COVID vaccines into clinical study.Prior to founding RVAC, Sean
Read more
Report
Joanna Wu, PhD, JD
Joanna has practiced law since 2003, with an initial focus on patent and FDA regulatory matters and later in other areas including corporate and technology transactions. She began her career with Ropes & Gray in Boston, followed by in-house experience in
Read more
Report
Sean Cao, PhD, MBA
Prior to joining ABio-X, Sean was a Managing Director of CBC Group, co-founded and served as the CEO of Everest Medicines and was the VP of Global Business Development at Simcere Pharmaceutical Group. Sean was also the President and Board Director at Simc
Read more
Report
Show more news

F-Prime Capital